Contact & Appointment Information
- Maryland Oncology Hematology
- 11886 Healing Way, Suite 701, Silver Spring, MD 20904
- Phone: 301-933-3216
- Email: radoncwhiteoak@usoncology.com
Department: Oncology
About Dr. Frederick Min
Cancer treatment demands skill, experience, and a focus on new options. Cancer care advances quickly today.Dr. Frederick Min fits this mold. He ranks among America’s Top 50 Doctors. From his base in Silver Spring, Maryland, Dr. Min shines in clinic work. He also brings deep know-how from clinical trials, drug creation, and world cancer leadership.
Patients who want top cancer care that fits their needs can count on Dr. Min. He offers smart advice shaped by years in research and new cancer treatments. His work goes past the office. He has published papers, run global trials, and speaks Korean. This helps him serve diverse patients with care that matches their culture.
A Base in Medicine and Research
Dr. Frederick Min started in cancer care through tough school and hands-on training. He finished internal medicine at Cornell University. Then he did a joint fellowship in drug studies and cancer at the National Institutes of Health and Georgetown University Medical Center. This mix built his skill in drug making and trial work.
In fellowship, Dr. Frederick Min stood out as a trial leader. He ran several Phase I studies. One key project involved Treanda (Bendamustine), now common for blood cancers. He also shared over 20 papers and talks at big events. These included ASCO, ASH, ASCPT, and FDA meetings.
Clinic Leadership and Drug Skills
Dr. Frederick Min links patient care with drug advances. After the fellowship, he joined Novartis as Medical Director and Global Project Leader. There, he guided five new cancer drugs across the U.S., Europe, and Asia.
He also sat on the Target Identification Committee. This group sought new targets for treatments that fit each patient. Dr. Min checked new molecules and helped move lab findings to patient use. This puts real gains in patients’ hands from matched care.
His full background lets Dr. Frederick Min give the newest, evidence-based treatments. He connects cancer advances to daily clinic work.
Clinic Work and Patient Views
Dr. Frederick Min now sees patients at Maryland Oncology Hematology in Silver Spring. He gives full cancer care that blends:
- Treatment plans tied to cancer type
- Entry to new drugs and trials
- Clear talks and support for patients
His patients gain from his skills as a doctor and researcher. He treats blood cancers and solid tumors. He picks options backed by fresh science. He honors each patient’s wishes and aims.
Dr. Frederick Min speaks Korean fluently. He talks straight to Korean patients for clear, comfy, culture-aware care.
Key Wins and Honors
Dr. Min’s cancer work earns praise:
- Rises Award from Washington Adventist Hospital
- Named “America’s Top Oncologist” in 2010 by Consumers’ Research Council of America
- These nods show his top clinic skill and lead in research-driven cancer care.
Fellowship and Key Training
Dr. Frederick Min did his joint fellowship in drug studies and cancer at NIH and Georgetown. It gave him a firm base in drug work, drug effects, and trial setup. He now adds safe new treatments to plans, especially in targeted cancer care and targeted drugs.
Papers and Research Gifts
Dr. Min adds much to cancer writing:
- Over 20 papers and talks at ASCO, ASH, ASCPT, and FDA events
- Led trials that won FDA okay
- Talks at world meetings on new drugs
His work shows a drive for patients now and cancer progress ahead.
World View in Cancer Care
As Global Project Leader at Novartis, Dr. Min worked across lands. He led drug growth in North America, Europe, and Asia. This wide view shapes his Maryland practice with global cancer norms.
His drug and matched medicine skills bring top trials and new drugs to local patients.
Drive for Trials and Matched Medicine
Dr. Min backs matched medicine hard. It uses a tumor’s genes and makeup for treatments. He draws on target groups and trial work to make options safe, strong, and right.
His patients get treatments fit to their tumors. This boosts results and cuts side effects.
Department
Department of Oncology and Hematology
Dr. Frederick Min works in the Oncology and Hematology Department at Maryland Oncology Hematology, Silver Spring, Maryland. The group handles:
- Finding and treating blood and solid cancers
- Adding aimed drugs and immune treatments
- Trials and new drug paths centered on patients
- Teamwork with surgeons, imaging experts, and helpers
- Teaching and advice for patients and kin
Here, Dr. Min gives top cancer care with kind support throughout treatment.
Patient Care Views
Dr. Min builds his care on:
- Proof-based treatment from new research and trials
- Plans fit to each patient’s makeup and wants
- Tools for patients to choose well
- Kind words that meet body and heart needs
He mixes science skills with heart. Patients feel backed and sure at every step.
wards and Honors
Professional groups and patient organizations have honored Dr. Min’s strong work:
- Rise’s Award – Washington Adventist Hospital
- America’s Top Oncologists (2010) – Consumers’ Research Council of America
These awards highlight his leadership, top clinical skills, and drive to improve cancer care.
FAQs
Q1. Who is Dr. Frederick Min?
Dr. Frederick Min is a board-certified oncologist and clinical researcher. He ranks among America’s Top 50 Doctors.
Q2. Does he focus on personalized medicine?
Yes. He uses treatments matched to tumor biology.
Q3. Does Dr. Min treat international patients?
Yes. He sees patients from the US and other countries.
Q4. What hospitals is Dr. Min affiliated with?
Maryland Oncology Hematology and Washington Adventist Hospital.
Q5. What types of cancer does he treat?
Blood cancers and solid tumors.
Q6. Does he have experience in global oncology?
Yes. He led cancer drug projects in the US, Europe, and Asia.
Q7. How can patients schedule an appointment?
Call 301-933-3216 or email radoncwhiteoak@usoncology.com.
Q8. Does Dr. Min participate in FDA meetings?
Yes. He has shared research and findings there.
Q9. Does he conduct clinical research?
Yes. He does this as a clinical researcher and global project leader.
Q10. Why is Dr. Min considered a top oncologist?
His skills blend clinical care, drug development leadership, research, and patient-focused personalized treatment.
Q11. Does Dr. Min speak other languages?
Yes. He speaks Korean fluently.
Q12. Has Dr. Min received awards?
Yes. These include the Rises Award and a spot among America’s Top Oncologists.
Q13. Is Dr. Min involved in research?
Yes. He has shared over 20 abstracts and articles at ASCO, ASH, ASCPT, and FDA meetings.
Q14. What is his educational background?
He trained in internal medicine at Cornell. He did fellowships at NIH and Georgetown University.
Q15. Does Dr. Min offer novel therapies?
Yes. He served as global project leader for new cancer treatments.
Q16. Has Dr. Min participated in clinical trials?
Yes. He led Phase I trials, including work on Treanda (Bendamustine).
Q17. What type of patients does he treat?
People with blood cancers and solid tumors.
Q18. Is Dr. Min board certified?
Yes. He holds certification in internal medicine and oncology.
Q19. What is Dr. Min’s specialty?
Oncology. He focuses on drug development and personalized medicine.
Q20. Where does Dr. Min practice?
Silver Spring, Maryland, United States.
